These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 29387962

  • 1. Long-term results of S-1 plus cisplatin with concurrent thoracic radiotherapy for locally advanced non-small-cell lung cancer.
    Taira T, Yoh K, Nagase S, Kubota K, Ohmatsu H, Niho S, Onozawa M, Akimoto T, Ohe Y, Goto K.
    Cancer Chemother Pharmacol; 2018 Mar; 81(3):565-572. PubMed ID: 29387962
    [Abstract] [Full Text] [Related]

  • 2. S-1 plus cisplatin with concurrent radiotherapy for locally advanced non-small cell lung cancer: a multi-institutional phase II trial (West Japan Thoracic Oncology Group 3706).
    Ichinose Y, Seto T, Sasaki T, Yamanaka T, Okamoto I, Takeda K, Tanaka M, Katakami N, Sawa T, Kudoh S, Saka H, Nishimura Y, Nakagawa K, Fukuoka M.
    J Thorac Oncol; 2011 Dec; 6(12):2069-75. PubMed ID: 22052226
    [Abstract] [Full Text] [Related]

  • 3. A phase II study of cisplatin plus S-1 with concurrent thoracic radiotherapy for locally advanced non-small-cell lung cancer: the Okayama Lung Cancer Study Group Trial 0501.
    Nogami N, Takigawa N, Hotta K, Segawa Y, Kato Y, Kozuki T, Oze I, Kishino D, Aoe K, Ueoka H, Kuyama S, Harita S, Okada T, Hosokawa S, Inoue K, Gemba K, Shibayama T, Tabata M, Takemoto M, Kanazawa S, Tanimoto M, Kiura K.
    Lung Cancer; 2015 Feb; 87(2):141-7. PubMed ID: 25534129
    [Abstract] [Full Text] [Related]

  • 4. Phase II study of oral S-1 and cisplatin with concurrent radiotherapy for locally advanced non-small-cell lung cancer.
    Kaira K, Tomizawa Y, Yoshino R, Yoshii A, Matsuura M, Iwasaki Y, Koga Y, Ono A, Nishioka M, Kamide Y, Hisada T, Ishizuka T, Shirai K, Ebara T, Saitoh J, Nakano T, Sunaga N.
    Lung Cancer; 2013 Dec; 82(3):449-54. PubMed ID: 24099666
    [Abstract] [Full Text] [Related]

  • 5. A randomised phase II trial of S-1 plus cisplatin versus vinorelbine plus cisplatin with concurrent thoracic radiotherapy for unresectable, locally advanced non-small cell lung cancer: WJOG5008L.
    Sasaki T, Seto T, Yamanaka T, Kunitake N, Shimizu J, Kodaira T, Nishio M, Kozuka T, Takahashi T, Harada H, Yoshimura N, Tsutsumi S, Kitajima H, Kataoka M, Ichinose Y, Nakagawa K, Nishimura Y, Yamamoto N, Nakanishi Y.
    Br J Cancer; 2018 Sep; 119(6):675-682. PubMed ID: 30206369
    [Abstract] [Full Text] [Related]

  • 6. Randomized phase II trial of S-1 plus cisplatin or docetaxel plus cisplatin with concurrent thoracic radiotherapy for inoperable stage III non-small cell lung cancer.
    Shimokawa T, Yamada K, Tanaka H, Kubota K, Takiguchi Y, Kishi K, Saito H, Hosomi Y, Kato T, Harada D, Otani S, Kasai T, Nakamura Y, Misumi T, Yamanaka T, Okamoto H.
    Cancer Med; 2021 Jan; 10(2):626-633. PubMed ID: 33319495
    [Abstract] [Full Text] [Related]

  • 7. Randomized phase II study of chemoradiotherapy with cisplatin + S-1 versus cisplatin + pemetrexed for locally advanced non-squamous non-small cell lung cancer: SPECTRA study.
    Niho S, Yoshida T, Akimoto T, Sakamaki K, Ono A, Seto T, Nishio M, Yamamoto N, Hida T, Okamoto H, Kurata T, Satouchi M, Goto K, Yamanaka T, Ohe Y.
    Lung Cancer; 2020 Mar; 141():64-71. PubMed ID: 31955002
    [Abstract] [Full Text] [Related]

  • 8. S-1 plus cisplatin with concurrent radiotherapy versus cisplatin alone with concurrent radiotherapy for stage III non-small cell lung cancer: a pilot randomized controlled trial.
    Yao L, Xu S, Xu J, Yang C, Wang J, Sun D.
    Radiat Oncol; 2015 Jan 09; 10():10. PubMed ID: 25572571
    [Abstract] [Full Text] [Related]

  • 9. Carboplatin, S-1 and concurrent thoracic radiotherapy for elderly patients with locally advanced non-small cell lung cancer: a multicenter Phase I/II study.
    Niho S, Hosomi Y, Okamoto H, Nihei K, Tanaka H, Hida T, Umemura S, Goto K, Akimoto T, Ohe Y.
    Jpn J Clin Oncol; 2019 Jul 01; 49(7):614-619. PubMed ID: 30916304
    [Abstract] [Full Text] [Related]

  • 10. Preoperative concurrent chemoradiotherapy of S-1/cisplatin for stage III non-small cell lung cancer.
    Yamaguchi M, Toyokawa G, Ohba T, Sasaki T, Kometani T, Hamatake M, Hirai F, Taguchi K, Yamanaka T, Seto T, Takenoyama M, Sugio K, Ichinose Y.
    Ann Thorac Surg; 2013 Nov 01; 96(5):1783-9. PubMed ID: 23998404
    [Abstract] [Full Text] [Related]

  • 11. Phase II trial of S-1 and cisplatin with concurrent radiotherapy for locally advanced non-small-cell lung cancer.
    Ohyanagi F, Yamamoto N, Horiike A, Harada H, Kozuka T, Murakami H, Gomi K, Takahashi T, Morota M, Nishimura T, Endo M, Nakamura Y, Tsuya A, Horai T, Nishio M.
    Br J Cancer; 2009 Jul 21; 101(2):225-31. PubMed ID: 19603031
    [Abstract] [Full Text] [Related]

  • 12. Concurrent chemoradiotherapy using cisplatin plus S-1, an oral fluoropyrimidine, followed by surgery for selected patients with stage III non-small cell lung cancer: a single-center feasibility study.
    Maruyama R, Hirai F, Ondo K, Kometani T, Hamatake M, Seto T, Sugio K, Ichinose Y.
    Surg Today; 2011 Nov 21; 41(11):1492-7. PubMed ID: 21969151
    [Abstract] [Full Text] [Related]

  • 13. Phase II trial of S-1 plus cisplatin combined with bevacizumab for advanced non-squamous non-small cell lung cancer (TCOG LC-1202).
    Miyanaga A, Kubota K, Hosomi Y, Okuma Y, Minato K, Fujimoto S, Okamoto H, Satouchi M, Isobe H, Aono H, Takiguchi Y, Gemma A, Tokyo Cooperative Oncology Group.
    Jpn J Clin Oncol; 2019 Aug 01; 49(8):749-754. PubMed ID: 31070750
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Phase I study of oral S-1 plus Cisplatin with concurrent radiotherapy for locally advanced non-small-cell lung cancer.
    Kaira K, Sunaga N, Yanagitani N, Kawata T, Utsugi M, Shimizu K, Ebara T, Kawamura H, Nonaka T, Ishikawa H, Sakurai H, Suga T, Hara K, Hisada T, Ishizuka T, Nakano T, Mori M.
    Int J Radiat Oncol Biol Phys; 2009 Sep 01; 75(1):109-14. PubMed ID: 18929446
    [Abstract] [Full Text] [Related]

  • 16. Preoperative chemoradiotherapy using cisplatin plus S-1 can induce downstaging in patients with locally advanced (stage III) non-small-cell lung cancer.
    Kato M, Onishi H, Matsumoto K, Tsuruta N, Higuchi K, Motoshita J, Katano M.
    Anticancer Res; 2012 Nov 01; 32(11):5099-104. PubMed ID: 23155287
    [Abstract] [Full Text] [Related]

  • 17. Dose-escalation study of three-dimensional conformal thoracic radiotherapy with concurrent S-1 and cisplatin for inoperable stage III non-small-cell lung cancer.
    Harada H, Nishio M, Murakami H, Ohyanagi F, Kozuka T, Ishikura S, Naito T, Kaira K, Takahashi T, Horiike A, Nishimura T, Yamamoto N.
    Clin Lung Cancer; 2013 Jul 01; 14(4):440-5. PubMed ID: 23540866
    [Abstract] [Full Text] [Related]

  • 18. Phase I/II trial of chemoradiotherapy with concurrent S-1 and cisplatin for clinical stage II/III esophageal carcinoma (JCOG 0604).
    Tahara M, Fuse N, Mizusawa J, Sato A, Nihei K, Kanato K, Kato K, Yamazaki K, Muro K, Takaishi H, Boku N, Ohtsu A.
    Cancer Sci; 2015 Oct 01; 106(10):1414-20. PubMed ID: 26250827
    [Abstract] [Full Text] [Related]

  • 19. Phase I study of pemetrexed and cisplatin with concurrent high-dose thoracic radiation after induction chemotherapy in patients with unresectable locally advanced non-small cell lung cancer.
    Mornex F, Peignaux K, Germain T, Wautot V, Chouaki N, Bourayou N, Tourani JM.
    Lung Cancer; 2013 Apr 01; 80(1):68-74. PubMed ID: 23332163
    [Abstract] [Full Text] [Related]

  • 20. S-1 plus cisplatin combination chemotherapy in patients with advanced non-small cell lung cancer: a multi-institutional phase II trial.
    Ichinose Y, Yoshimori K, Sakai H, Nakai Y, Sugiura T, Kawahara M, Niitani H.
    Clin Cancer Res; 2004 Dec 01; 10(23):7860-4. PubMed ID: 15585618
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.